• Indications
  • Open Access TIMES Journals
Login Register
Login Register
Indications
  • Oncology · Hematology
  • Spine Surgery
  • Cardiovascular
  • Diabetes + Endocrinology
  • Pneumology
  • Ophthalmology
  • Gynecology · Urology
  • Dermatology · Immunology · Rheumatology
  • Neurology · Psychiatry
  • Gastroenterology
  • Infectiology · Anesthesiology · Pain
  • Primary Care
Open Access TIMES Journals
  • Oncology · Hematology
  • Spine Surgery
  • Cardiovascular
  • Diabetes + Endocrinology
  • Pneumology
  • Ophthalmology
  • Gynecology · Urology
  • Dermatology · Immunology · Rheumatology
  • Neurology · Psychiatry
  • Gastroenterology
  • Infectiology · Anesthesiology · Pain
  • Primary Care
Cardiovascular

Cardiovascular

Case Reports
Congress News
Webinar
E-Learning
Faculty
Homepage >
Cardiovascular >
Articles

Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy

Further Publications
Share:
Do you want to read an article? Please log in or register.
Register for Free
Remember me
Forgot password? Click here

Related content

Heart, Artery and Coronary Diseases
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study
ESC Heart Fail
Tini G, Musumeci B, Milani P, Zampieri M, Caponetti AG, Fabris F, Foli A, Argirò A, Mazzoni C, Gagliardi C, Longhi S, Saturi G, Vergaro G, Aimo A, De Fazio L, Varrà GG, Serenelli M, Fabbri G, De Michieli L, Palmiero G, Ciliberti G, Carigi S, Zanoletti M, Mandoli GE, Lucchi GR, Rella V, Monti E, Gardini E, Bartolotti M, Crotti L, Merli E, Mussinelli R, Vianello PF, Cameli M, Marzo F, Guerra F, Limongelli G, Cipriani A, Perlini S, Obici L, Perfetto F, Barbato E, Porto I, Sinagra G, Merlo M, Emdin M, Biagini E, Cappelli F, Palladini G, Canepa M
doi: 10.1002/ehf2.15091
Heart FailureFurther Publications
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration
JAMA Cardiol
Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, Sinigiani G, Cipriani A, Aimo A, Tomasoni D, Zampieri M, Cantone A, Allegro V, Vergaro G, Masri A, Urey M, Ioannou A, Petrie A, Noory N, Gustafsson F, Poledniczek M, Emdin M, Metra M, Sinagra G, Martinez-Naharro A, Wechalekar AD, Lachman H, Whelan C, Hawkins PN, Solomon SD, Gillmore JD, Fontana M
doi: 10.1001/jamacardio.2024.5221
Heart, Artery and Coronary Diseases
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing-A multicentre study
ESC Heart Fail
Willixhofer R, Contini M, Emdin M, Magrì D, Bonomi A, Salvioni E, Celeste F, Del Torto A, Passino C, Capelle CDJ, Arzilli C, Fiori E, Capra N, Kronberger C, Ermolaev N, Kammerlander A, Musumeci B, Vergaro G, Castiglione V, Rettl R, Tini G, Baggiano A, Fabiani I, Sciomer S, Badr Eslam R, Agostoni P
doi: 10.1002/ehf2.15147
Heart Failure
Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease
ESC Heart Fail
Zahir Anjum D, Bonde AN, Fosbol E, Hartwell Garred C, Gislason G, Elmegaard M, Knigge P, Torp-Pedersen C, Andersson C, Pfeffer MA, Jhund PS, McMurray JJV, Petrie MC, Kober L, Schou M
doi: 10.1002/ehf2.14933
Cardiac Arrest or Death
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy
Circ Arrhythm Electrophysiol
Abdelfattah OM, Sayed A, Al-Jwaid A, Hassan A, Abu Jazar D, Narayanan A, Link MS, Martinez MW
doi: 10.1161/CIRCEP.124.013479
Heart, Artery and Coronary Diseases
Prediction of Major Arrhythmic Outcomes in Ischemic Cardiomyopathy: Value of Hibernating Myocardium in PET/CT
Eur Heart J Cardiovasc Imaging
Kovacs B, Gllareva V, Ruschitzka F, Duru F, Kaufmann PA, Buechel RR, Benz DC, Saguner AM
doi: 10.1093/ehjci/jeae232
Further Publications
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis
Eur Heart J
Nitsche C, Dobner S, Rosenblum HR, Patel KP, Longhi S, Yilmaz A, Merlo M, Papathanasiou M, Griffin J, Oerlemans MIFJ, Gama F, Hamdan A, Kelion AD, Schuster A, Glaveckaité S, Akyol N, Porcari A, Schlender L, Capovilla T, Autherith M, Hauptmann L, Halavina K, Cavalcante JL, Fontana M, Scully PR, Moon JC, Mascherbauer J, Ristl R, Biagini E, Stortecky S, Maurer MS, Treibel TA, AS-Amyloidosis Consortium
doi: 10.1093/eurheartj/ehaf362
Heart Failure
Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement
Clin Res Cardiol
Esteban-Fernández A, Gómez-Otero I, López-Fernández S, López-Vilella R, Pastor-Pérez F, Otero-García Ó, Rodríguez-Santamarta M, García-Vega D, Fluvià P, Donoso-Trenado V, Sánchez-Corral E, García-Pinilla JM, Bonilla-Palomas JL, López López A, González-Juanatey JR, Bonet LA
doi: 10.1007/s00392-025-02663-y
Heart, Artery and Coronary DiseasesTherapy and Intervention
The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes
Eur J Cardiothorac Surg
Lansac E, Veen KM, Joseph A, Jaber PB, Sossi F, Das-Gupta Z, Aktaa S, Rafael Sádaba J, Thourani VH, Dahle G, Szeto WY, Bakaeen F, Aikawa E, Schoen FJ, Girdauskas E, Almeida A, Zuckermann A, Meuris B, Stott J, Kluin J, Meel R, Woan W, Colgan D, Jneid H, Balkhy H, Szerlip M, Preventza O, Shah P, Rigolin VH, Medica S, Holmes P, Sitges M, Pibarot P, Donal E, Hahn RT, Takkenberg JJM
doi: 10.1093/ejcts/ezae254
  • Contact us
  • About us
  • Privacy Policy & Disclaimer
  • Online Media 2025 Data
  • Imprint
healthbook is a registered trademark. Copyright © 2025 healthbook